Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Finkel

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|January 17, 1980
The FDA's classification system for new drugs. An evaluation of therapeutic gainM J Finkel
The New England Journal of Medicine|March 13, 1980
Drugs of limited commercial valueM J Finkel
Pediatric Pharmacology (New York, N.Y.)|January 1, 1980
Drug studies in childrenM J Finkel
The New England Journal of Medicine|September 6, 1984
Adoption of orphan products by the pharmaceutical industryM J Finkel
Clinical Therapeutics|January 1, 1984
Phenytoin revisitedM J Finkel
Public Health Reports (Washington, D.C. : 1974)|May 1, 1984
The Orphan Drug Act and the Federal Government's Orphan Products Development ProgramM J Finkel
British Medical Journal|March 11, 1978
Salbutamol: lack of evidence of tumour induction in manM J Finkel
Journal of the American Dental Association (1939)|February 4, 2010
Treating another's patientsSheldon J Finkel
PNAS Nexus|October 23, 2023
The social media discourse of engaged partisans is toxic even when politics are irrelevantMichalis Mamakos, Eli J Finkel
Lancet (London, England)|September 23, 1995
White-blood-cell monitoring and clozapineM J Finkel, F Arellano
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|January 17, 1980
The FDA's classification system for new drugs. An evaluation of therapeutic gainM J Finkel
The New England Journal of Medicine|March 13, 1980
Drugs of limited commercial valueM J Finkel
Pediatric Pharmacology (New York, N.Y.)|January 1, 1980
Drug studies in childrenM J Finkel
The New England Journal of Medicine|September 6, 1984
Adoption of orphan products by the pharmaceutical industryM J Finkel
Clinical Therapeutics|January 1, 1984
Phenytoin revisitedM J Finkel
Public Health Reports (Washington, D.C. : 1974)|May 1, 1984
The Orphan Drug Act and the Federal Government's Orphan Products Development ProgramM J Finkel
British Medical Journal|March 11, 1978
Salbutamol: lack of evidence of tumour induction in manM J Finkel
Journal of the American Dental Association (1939)|February 4, 2010
Treating another's patientsSheldon J Finkel
PNAS Nexus|October 23, 2023
The social media discourse of engaged partisans is toxic even when politics are irrelevantMichalis Mamakos, Eli J Finkel
Lancet (London, England)|September 23, 1995
White-blood-cell monitoring and clozapineM J Finkel, F Arellano
Pageof 18